Experts focus discussion on FDA's role in comparative effectiveness

02/18/2010 | Medical Devices Today

The FDA's role in comparative-effectiveness research was the focus during a meeting called by a task force of the agency's device center. Diana Zuckerman, a patient advocate, suggested the FDA use comparative studies conducted by groups such as the Agency for Healthcare Research and Quality in assessing the efficacy of new and older devices. Timothy Wright, a principal scientist at a New York hospital, said he believes the agency's role is not comparative effectiveness, but public health.

View Full Article in:

Medical Devices Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL